199 related articles for article (PubMed ID: 20492502)
1. Course of disease and survival after onset of decompensation in hepatitis B virus-related cirrhosis.
Das K; Das K; Datta S; Pal S; Hembram JR; Dhali GK; Santra A; Chowdhury A
Liver Int; 2010 Aug; 30(7):1033-42. PubMed ID: 20492502
[TBL] [Abstract][Full Text] [Related]
2. Natural history of hepatitis B virus-related cirrhotic patients hospitalized to control ascites.
Kim SU; Han KH; Nam CM; Park JY; Kim DY; Chon CY; Ahn SH
J Gastroenterol Hepatol; 2008 Nov; 23(11):1722-7. PubMed ID: 18717757
[TBL] [Abstract][Full Text] [Related]
3. The natural history of hepatitis B virus cirrhosis after the first hepatic decompensation in Tunisia.
Jmaa A; Ksiaa M; Ben Slama A; Kahloun A; Jmaa R; Harrabi I; Golli L; Ajmi S
Tunis Med; 2012 Feb; 90(2):172-6. PubMed ID: 22407631
[TBL] [Abstract][Full Text] [Related]
4. Natural history of chronic hepatitis B virus infection: what determines prognosis after cirrhotic decompensation?
Wei L
J Gastroenterol Hepatol; 2008 Nov; 23(11):1631-2. PubMed ID: 19120855
[No Abstract] [Full Text] [Related]
5. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.
Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F
World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387
[TBL] [Abstract][Full Text] [Related]
6. Antiviral therapy delays esophageal variceal bleeding in hepatitis B virus-related cirrhosis.
Li CZ; Cheng LF; Li QS; Wang ZQ; Yan JH
World J Gastroenterol; 2013 Oct; 19(40):6849-56. PubMed ID: 24187460
[TBL] [Abstract][Full Text] [Related]
7. Patients with liver cirrhosis show worse survival if decompensation occurs later during course of disease than at diagnosis.
Nilsson E; Anderson H; Sargenti K; Lindgren S; Prytz H
Scand J Gastroenterol; 2018 Apr; 53(4):475-481. PubMed ID: 29513096
[TBL] [Abstract][Full Text] [Related]
8. Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study.
Bruno S; Zuin M; Crosignani A; Rossi S; Zadra F; Roffi L; Borzio M; Redaelli A; Chiesa A; Silini EM; Almasio PL; Maisonneuve P
Am J Gastroenterol; 2009 May; 104(5):1147-58. PubMed ID: 19352340
[TBL] [Abstract][Full Text] [Related]
9. Different patterns of decompensation in patients with alcoholic vs. non-alcoholic liver cirrhosis.
Wiegand J; Kühne M; Pradat P; Mössner J; Trepo C; Tillmann HL
Aliment Pharmacol Ther; 2012 Jun; 35(12):1443-50. PubMed ID: 22530565
[TBL] [Abstract][Full Text] [Related]
10. Preemptive antiviral therapy with entecavir can reduce acute deterioration of hepatic function following transarterial chemoembolization.
Yoo SH; Jang JW; Kwon JH; Jung SM; Jang B; Choi JY
Clin Mol Hepatol; 2016 Dec; 22(4):458-465. PubMed ID: 28081589
[TBL] [Abstract][Full Text] [Related]
11. Natural history of compensated viral B and D cirrhosis.
Gheorghe L; Iacob S; Simionov I; Vadan R; Gheorghe C; Iacob R; Parvulescu I; Constantinescu I
Rom J Gastroenterol; 2005 Dec; 14(4):329-35. PubMed ID: 16400347
[TBL] [Abstract][Full Text] [Related]
12. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
[TBL] [Abstract][Full Text] [Related]
13. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
[TBL] [Abstract][Full Text] [Related]
14. Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort).
Trinchet JC; Bourcier V; Chaffaut C; Ait Ahmed M; Allam S; Marcellin P; Guyader D; Pol S; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Goria O; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Buffet C; Bacq Y; Wartelle C; Dao T; Benhamou Y; Pilette C; Silvain C; Christidis C; Capron D; Thiefin G; Hillaire S; Di Martino V; Nahon P; Chevret S;
Hepatology; 2015 Sep; 62(3):737-50. PubMed ID: 25678021
[TBL] [Abstract][Full Text] [Related]
15. Anti-viral therapy is associated with improved survival but is underutilised in patients with hepatitis B virus-related hepatocellular carcinoma: real-world east and west experience.
Chen VL; Yeh ML; Le AK; Jun M; Saeed WK; Yang JD; Huang CF; Lee HY; Tsai PC; Lee MH; Giama N; Kim NG; Nguyen PP; Dang H; Ali HA; Zhang N; Huang JF; Dai CY; Chuang WL; Roberts LR; Jun DW; Lim YS; Yu ML; Nguyen MH
Aliment Pharmacol Ther; 2018 Jul; 48(1):44-54. PubMed ID: 29797518
[TBL] [Abstract][Full Text] [Related]
16. Trends in Characteristics, Mortality, and Other Outcomes of Patients With Newly Diagnosed Cirrhosis.
Orman ES; Roberts A; Ghabril M; Nephew L; Desai AP; Patidar K; Chalasani N
JAMA Netw Open; 2019 Jun; 2(6):e196412. PubMed ID: 31251379
[TBL] [Abstract][Full Text] [Related]
17. Mortality risk according to different clinical characteristics of first episode of liver decompensation in cirrhotic patients: a nationwide, prospective, 3-year follow-up study in Italy.
Bruno S; Saibeni S; Bagnardi V; Vandelli C; De Luca M; Felder M; Fracanzani AL; Prisco C; Vitaliani G; Simone L; Gaeta GB; Stanzione M; Persico M; Furlan C; Stroffolini T; Salerno F; Maisonneuve P; Almasio PL;
Am J Gastroenterol; 2013 Jul; 108(7):1112-22. PubMed ID: 23732467
[TBL] [Abstract][Full Text] [Related]
18. Antiviral treatment and liver-related complications in hepatitis delta.
Wranke A; Serrano BC; Heidrich B; Kirschner J; Bremer B; Lehmann P; Hardtke S; Deterding K; Port K; Westphal M; Manns MP; Cornberg M; Wedemeyer H
Hepatology; 2017 Feb; 65(2):414-425. PubMed ID: 27770553
[TBL] [Abstract][Full Text] [Related]
19. Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma.
Cabibbo G; Petta S; Barbara M; Attardo S; Bucci L; Farinati F; Giannini EG; Negrini G; Ciccarese F; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Borzio F; Sacco R; Virdone R; Marra F; Mega A; Morisco F; Benvegnù L; Gasbarrini A; Svegliati-Baroni G; Foschi FG; Olivani A; Masotto A; Nardone G; Colecchia A; Persico M; Craxì A; Trevisani F; Cammà C;
J Hepatol; 2017 Jul; 67(1):65-71. PubMed ID: 28192185
[TBL] [Abstract][Full Text] [Related]
20. Treatment of HBV related cirrhosis.
van Bömmel F; Berg T
Liver Int; 2013 Feb; 33 Suppl 1():176-81. PubMed ID: 23286862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
